DAO and schizophrenia: On the other hand, piperideine-2-carboxylic acid is an inhibitor of d-amino acid oxidase, which regulates levels of d-serine, a co-agonist of the NMDA receptor, and thus implicating lysine metabolism in schizophrenia (see review by Hallen et al. [136]).